Brandinium

Trademark search for:

GIVAREX

EXPIRED USPTO USPTO

No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.

Trademark records may change over time. For the most up-to-date trademark status, domain availability, and social handle checks, run a live search.

Live search · Most up-to-date results
Also check across: EU CA AU NZ CH

USPTO Filing History

Key events recorded for this trademark application

  • 1995-01-03 — Application filed
  • 1995-05-08 — Assigned to examiner
  • 1995-05-19 — Final disposition recorded
  • 1995-07-11 — Correspondence received in law office
  • 1995-08-11 — Letter of suspension mailed
  • 1996-02-17 — Inquiry as to suspension mailed
  • 1997-10-03 — Assigned to examiner
  • 1997-10-03 — Letter of suspension mailed
  • 1998-03-13 — Assigned to examiner
  • 1998-03-13 — Final disposition recorded
  • 1998-05-08 — Letter of suspension mailed
  • 1998-10-13 — Correspondence received in law office
  • 1998-11-13 — Letter of suspension mailed
  • 1999-05-18 — Inquiry as to suspension mailed
  • 1999-07-14 — Letter of suspension mailed
  • 1999-11-18 — Correspondence received in law office
  • 2000-02-10 — Inquiry as to suspension mailed
  • 2000-05-12 — Letter of suspension mailed
  • 2000-08-14 — Correspondence received in law office
  • 2001-03-13 — Inquiry as to suspension mailed
  • 2002-02-28 — Assigned to examiner
  • 2002-02-28 — Application abandoned
  • 2002-03-07 — Petition to revive-received
  • 2002-06-19 — Correspondence received in law office
  • 2002-07-23 — Incomplete petition notice mailed
  • 2002-08-19 — Paper received
  • 2002-08-19 — Communication received from petitioner
  • 2002-09-13 — Petition to revive-granted
  • 2002-09-18 — Letter of suspension mailed
  • 2002-10-28 — Paper received
  • 2002-10-28 — Sec. 44(d) claim deleted
  • 2002-11-01 — Approved for pub - principal register
  • 2003-01-08 — Notice of publication
  • 2003-01-28 — Published for opposition
  • 2003-04-22 — Noa mailed - sou required from applicant
  • 2003-07-22 — Teas statement of use received
  • 2003-07-22 — Use amendment filed
  • 2003-08-09 — Statement of use processing complete
  • 2003-08-19 — Case file in ticrs
  • 2003-08-21 — Assigned to examiner
  • 2003-08-21 — Allowed principal register - sou accepted
  • 2003-11-11 — Registered-principal register
  • 2005-03-15 — Teas revoke/app/change addr of atty/dom rep received
  • 2005-03-15 — Attorney/dom.rep.revoked and/or appointed
  • 2010-06-19 — Cancelled sec. 8 (6-yr)
  • 2010-06-19 — Final status recorded

Owner Information

ALTAREX MEDICAL CORP.
EDMONTON, ALBERTA CA
ALTAREX CORP.
EDMONTON, ALBERTA CA
ALTAREX CORP.
EDMONTON, ALBERTA CA
ALTAREX INC.
EDMONTON, ALBERTA CA
Biomira Research Inc.
Edmonton, Alberta T6G 2N8 CA
Biomira Research Inc.
Edmonton, Alberta T6G 2N8 CA

Correspondent

CHRISTOPHER J KULISH HOLLAND & HART LLP
PO BOX 8749
555 17TH ST STE 3200
DENVER, CO 80201

Filing Details

Filing Date:
1995-01-03
Status Date:
2010-06-19
Category:
Pharmaceuticals
Filing Year:
1995

Disclaimer: This page is informational only and does not constitute legal advice. Trademark availability depends on jurisdiction, usage, and legal interpretation.